Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype
Peter Solar, Laurie Feldman, Jee-Yeong Jeong, Jacqueline R. Busingye, Arthur J. SytkowskiVolume:
122
Year:
2008
Language:
english
Pages:
8
DOI:
10.1002/ijc.23071
File:
PDF, 351 KB
english, 2008